Tau phosphorylation in neuronal cell function and dysfunction

Cited by (626)

Items 301–400 of 626

1. The Neurovascular Unit as a Locus of Injury in Low-Level Blast-Induced Neurotrauma
   Gregory A. Elder, Miguel A. Gama Sosa, Rita De Gasperi, Georgina S. Perez Garcia, Gissel M. Perez, Rania Abutarboush, Usmah Kawoos, Carolyn Wei Zhu, William G.M. Janssen, James R. Stone et al. · 2024 · International Journal of Molecular Sciences
2. A Pathophysiological Intersection of Diabetes and Alzheimer’s Disease
   Maša Čater, Sabine M. Hölter · 2022 · International Journal of Molecular Sciences
3. Pathological Impact of Tau Proteolytical Process on Neuronal and Mitochondrial Function: a Crucial Role in Alzheimer’s Disease
   Margrethe A. Olesen, Rodrigo A. Quintanilla · 2023 · Molecular Neurobiology
4. Cytomegalovirus infection induces Alzheimer’s disease-associated alterations in tau
   Mody, Prapti H., Marvin, Kelsey N., Hynds, DiAnna L., Hanson, Laura K. · 2023 · Journal of NeuroVirology
5. MicroRNAs and synapse turnover in Alzheimer’s disease
   Sarthak Dalal, Jaime Ramirez-Gomez, Bhupender Sharma, Davin Devara, Subodh Kumar · 2024 · Ageing Research Reviews
6. Insulin-induced neurite-like process outgrowth: Acceleration of tau protein synthesis via a phosphoinositide 3-kinase∼mammalian target of rapamycin pathway
   Nemoto, Takayuki, Yanagita, Toshihiko, Satoh, Shinya, Maruta, Toyoaki, Kanai, Tasuku, Murakami, Manabu, Wada, Akihiko · 2011 · Neurochemistry International
7. Glycogen Synthase Kinase 3: A Point of Integration in Alzheimer's Disease and a Therapeutic Target?
   Siddhartha Mondragón‐Rodríguez, George L. Perry, Xiongwei Zhu, Paula Isabel Moreira, Sylvain Williams · 2012 · International Journal of Alzheimer s Disease
8. Inhibition of calcineurin by infusion of CsA causes hyperphosphorylation of tau and is accompanied by abnormal behavior in mice
   Dayu Yu, Jing Luo, Fan Bu, Gaojie Song, Lai-qun Zhang, Qun Wei · 2006 · Biological Chemistry
9. Neuroprotective effects of Bergenia ciliata on NMDA induced injury in SH-SY5Y cells and attenuation of cognitive deficits in scopolamine induced amnesia in rats
   Barai, Priyal, Raval, Nisith, Acharya, Sanjeev, Acharya, Niyati · 2018 · Biomedicine & Pharmacotherapy
10. Cannabidiol – A phytocannabinoid that widely affects sphingolipid metabolism under conditions of brain insulin resistance
    Tomasz Charytoniuk, Klaudia Sztolsztener, Ewa Harasim‐Symbor, Klaudia Berk, Adrian Chabowski, Karolina Konstantynowicz-Nowicka · 2021 · Biomedicine & Pharmacotherapy
11. Stress Activated MAP Kinases and Cyclin-Dependent Kinase 5 Mediate Nuclear Translocation of Nrf2 via Hsp90α-Pin1-Dynein Motor Transport Machinery
    Tetsuro Ishii, Eiji Warabi, Giovanni E. Mann · 2023 · Antioxidants
12. The Neuronal Cytoskeleton as a Potential Target in the Developmental Neurotoxicity of Organophosphorothionate Insecticides
    John Flaskos · 2014 · Basic & Clinical Pharmacology & Toxicology
13. Protein kinase C activation causes neurite retraction via cyclin D 1 and p60‐katanin increase in rat hippocampal neurons
    Şirin Korulu, Ayşegül Yıldız, Meral Yüksel, Arzu Karabay · 2013 · European Journal of Neuroscience
14. Human Neural Stem Cell Systems to Explore Pathogen-Related Neurodevelopmental and Neurodegenerative Disorders
    Matteo Baggiani, Maria Teresa Dell'Anno, M. Pistello, L. Conti, M. Onorati · 2020 · Cells
15. Predictive and prognostic values of Tau and BubR1 protein in prostate cancer and their relationship to the Gleason score
    Yalcin Cirak, Banu Sarsık, Burcu Çakar, Sait Şen, Adnan Şimşir, Rüçhan Uslu · 2013 · Medical Oncology
16. Should Alzheimer's disease be equated with human brain ageing?: A maladaptive interaction between brain evolution and senescence
    David Neill · 2011 · Ageing Research Reviews
17. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy
    Andrea Popelová, Veronika Pražienková, Barbora Neprašová, Barbora Judita Kasperová, Lucie Hrubá, Martina Holubová, Jana Zemenová, David L Blum, Blanka Železná, Marie‐Christine Galas et al. · 2018 · Journal of Alzheimer s Disease
18. Glial cell line-derived neurotrophic factor–mediated enteric neuronal survival involves glycogen synthase kinase-3β phosphorylation and coupling with 14-3-3
    Simon Musyoka Mwangi, Mallappa Anitha, Haian Fu, Shanthi V. Sitaraman, Shanthi Srinivasan · 2006 · Neuroscience
19. Lessons from genome‐wide association studies findings in Alzheimer's disease
    Clayton Franco Moraes, Tulio Cesar de Lima Lins, Einstein F. CARMARGOS, Janeth O. S. Naves, Rinaldo Wellerson Pereira, Otávio de Tolêdo Nóbrega · 2011 · Psychogeriatrics
20. Cerebral transcriptome analysis reveals age-dependent progression of neuroinflammation in P301S mutant tau transgenic male mice
    Joonki Kim, Sharmelee Selvaraji, Sung Wook Kang, Wei Thye Lee, Christopher Chen, Hyungwon Choi, Edward H. Koo, Dong‐Gyu Jo, Kah Leong Lim, Yun-An Lim et al. · 2019 · Brain Behavior and Immunity
21. An emerging role for stress granules in neurodegenerative disease and hearing loss
    Jack L. Martin, Sally J. Dawson, Jonathan E. Gale · 2022 · Hearing Research
22. Activity-dependent tau cleavage by caspase-3 promotes neuronal dysfunction and synaptotoxicity
    Carli K. Opland, Miles R. Bryan, Braxton Harris, Jake McGillion-Moore, Xu Tian, Youjun Chen, Michelle S. Itano, Graham H. Diering, Rick B. Meeker, Todd J. Cohen · 2023 · iScience
23. Neurites regrowth of cortical neurons by GSK3β inhibition independently of Nogo receptor 1
    Oscar Seira, Rosalina Gavı́n, Vanessa Gil, Franc Llorens, Alejandra Rangel, Eduardo Soriano, José Antonio del Rı́o · 2010 · Journal of Neurochemistry
24. GSK-3β may be involved in hippocampal mossy fiber sprouting in the pentylenetetrazole-kindling model
    Wenjiao Huang, Fafa Tian, Jin-Mei Chen, Ting-hui Guo, YUN-FENG MA, Jia Ni Fang, Jing Dang, Mingyu Song · 2013 · Molecular Medicine Reports
25. The Differences between Blast-Induced and Sports-Related Brain Injuries
    Yun Chen, Wei Huang, Shlomi Constantini · 2013 · Frontiers in Neurology
26. Proteostasis and Mitochondrial Role on Psychiatric and Neurodegenerative Disorders: Current Perspectives
    Pablo Olivero, Carlo Lozano, Ramón Sotomayor‐Zárate, Nicolás Meza-Concha, Marcelo Arancibia M, Claudio Córdova, Wilfredo Alejandro González‐Arriagada, Ricardo Ramírez-Barrantes, Ivanny Marchant · 2018 · Neural Plasticity
27. Differential effects of 14-3-3 dimers on Tau phosphorylation, stability and toxicity in vivo
    Katerina Papanikolopoulou, Sofia Grammenoudi, Martina K. Samiotaki, Efthimios M. C. Skoulakis · 2018 · Human Molecular Genetics
28. The impact of tau hyperphosphorylation at Ser 262 on memory and learning after global brain ischaemia in a rat model of reversible cardiac arrest
    Shohreh Majd, John H. T. Power, Simon Andrea Koblar, Hugh J. M. Grantham · 2016 · IBRO Reports
29. An Analysis of the Neurological and Molecular Alterations Underlying the Pathogenesis of Alzheimer’s Disease
    Chantal Vidal, Zhang Li · 2021 · Cells
30. Contributive Role of Hyperglycemia and Hypoglycemia Towards the Development of Alzheimer’s Disease
    Riya Chakrabarty, Sumaira Yousuf, Mahendra P Singh · 2022 · Molecular Neurobiology
31. Lymphocytes with Cytotoxic Activity Induce Rapid Microtubule Axonal Destabilization Independently and before Signs of Neuronal Death
    Nichole M. Miller, Leah P. Shriver, Vijaya Lakshmi Bodiga, Avijit Ray, Sreemanti Basu, Rajiv Ahuja, Arundhati Jana, Kalipada Pahan, Bonnie N. Dittel · 2013 · ASN NEURO
32. Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease
    Fabiha Zaheen Khan, Md Shaki Mostaid, Mohd Nazmul Hasan Apu · 2022 · Heliyon
33. The development and benefits of metformin in various diseases
    Ying Dong, Yingbei Qi, Haowen Jiang, Mi Tian, Yunkai Zhang, Chang Si Peng, Wan-Chen Li, Yi Zhang, Yubo Zhou, Yi Zang et al. · 2023 · Frontiers of Medicine
34. Site‐specific phosphorylation of tau impacts mitochondrial function and response to stressors
    Michael O. Isei, Peter Girardi, Joel Rodwell‐Bullock, Keith W. Nehrke, Gail V.W. Johnson · 2023 · Journal of Neurochemistry
35. Phospho-Tau Protein Expression in the Cell Cycle of SH-SY5Y Neuroblastoma Cells: A Morphological Study
    Paola Flores-Rodríguez, Charles R. Harrington, Claude M. Wischik, Vanessa Ibarra-Bracamontes, Natanael Zarco, Araceli Navarrete, Alejandra Martínez-Maldonado, Parménides Guadarrama-Ortíz, Ignacio Villanueva‐Fierro, Miguel Ángel Ontiveros‐Torres et al. · 2019 · Journal of Alzheimer s Disease
36. Microtubule alterations may destabilize photoreceptor integrity: Age-related microtubule changes and pattern of expression of MAP-2, Tau and hyperphosphorylated Tau in aging human photoreceptor cells
    Tapas Chandra Nag, Poorti Kathpalia, Shashi Wadhwa · 2020 · Experimental Eye Research
37. Differential compartmental processing and phosphorylation of pathogenic human tau and native mouse tau in the line 66 model of frontotemporal dementia
    Nora Lemke, Valeria Melis, Dilyara Lauer, Mandy Magbagbeolu, Boris Neumann, Charles R. Harrington, Gernot Riedel, Claude M. Wischik, Franz Theuring, Karima Schwab · 2020 · Journal of Biological Chemistry
38. Caffeine Restores Neuronal Damage and Inflammatory Response in a Model of Intraventricular Hemorrhage of the Preterm Newborn
    Pilar Alves-Martínez, Isabel Atienza‐Navarro, María Vargas-Soria, María José Carranza-Naval, Carmen Infante‐Garcia, Isabel Benavente‐Fernández, Àngel del Marco, Simón Pedro Lubián‐López, Mónica Garcı́a-Alloza · 2022 · Frontiers in Cell and Developmental Biology
39. Pharmacophore Modeling, Ensemble Docking, Virtual Screening, and Biological Evaluation on Glycogen Synthase Kinase‐3β
    Gang Fu, Prasanna Sivaprakasam, Olivia Reed Dale, Susan P. Manly, Stephen J. Cutler, Robert J. Doerksen · 2014 · Molecular Informatics
40. Modulation of AβPP and GSK3β by Endoplasmic Reticulum Stress and Involvement in Alzheimer’s Disease
    Xin-jun Liu, Jun Wei, Yinghui Shang, Han‐Chang Huang, Fengxue Lao · 2017 · Journal of Alzheimer s Disease
41. Emerging paradigms in treating cerebral infarction with nanotheranostics: opportunities and clinical challenges
    Waleed Hassan Almalki, Saad Ali Alghamdi, Abdulaziz Alzahrani, Wenzhi Zhang · 2020 · Drug Discovery Today
42. An overview on microglial origin, distribution, and phenotype in Alzheimer's disease
    Rezwanul Islam, Hadi Hasan Choudhary, Robin G. Rajan, Frank D. Vrionis, Khalid A. Hanafy · 2022 · Journal of Cellular Physiology
43. Alcohol-drinking during later life by C57BL/6J mice induces sex- and age-dependent changes in hippocampal and prefrontal cortex expression of glutamate receptors and neuropathology markers
    Karen Kathleen Szumlinski, Jessica N. Herbert, Brenda Mejia Espinoza, Lauren E. Madory, Samantha L. Scudder · 2023 · Addiction Neuroscience
44. Emerging roles of Axin in cerebral cortical development
    Ye Tao, Amy K.Y. Fu, Nancy Y. Ip · 2015 · Frontiers in Cellular Neuroscience
45. Hyperphosphorylation of Tau Protein in DownâÂÂs Dementia andAlzheimerâÂÂs Disease: Methylation and Implications in Prevention andTherapy
    T. Nichols · 2014 · Journal of Alzheimer’s Disease & Parkinsonism
46. Design and pharmaceutical applications of proteolysis-targeting chimeric molecules
    Yuqing Liang, Kutty Selva Nandakumar, Kui Cheng · 2020 · Biochemical Pharmacology
47. Laterality and region-specific tau phosphorylation correlate with PTSD-related behavioral traits in rats exposed to repetitive low-level blast
    Georgina S. Perez Garcia, R. De Gasperi, M. Gama Sosa, Gissel M. Perez, Alena Otero-Pagan, Dylan Pryor, Rania Abutarboush, U. Kawoos, P. Hof, D. Dickstein et al. · 2021 · Acta Neuropathologica Communications
48. Racemization in Post-Translational Modifications Relevance to Protein Aging, Aggregation and Neurodegeneration: Tip of the Iceberg
    Victor V. Dyakin, Thomas Wısnıewskı, Ábel Lajtha · 2021 · Symmetry
49. A New Use for an Old Treatment: Radiation Therapy and Alzheimer's Disease
    George David Wilson, Brian Marples · 2016 · Radiation Research
50. Synthesis and conformational properties of phosphopeptides related to the human tau protein
    Jintang Du, Yanmei Li, Qing‐Feng Ma, Qiang Wei, Yufen Zhao, Hiroshi Abe, Kenji Kanazawa, Xurong Qin, Ryousuke Aoyagi, Yasuko Ishizuka et al. · 2005 · Regulatory Peptides
51. Phospho-Tau and Chromatin Landscapes in Early and Late Alzheimer’s Disease
    Laura Gil, Sandra Aurora Niño, Carmen Guerrero, María Esther Jiménez-Capdeville · 2021 · International Journal of Molecular Sciences
52. Maintaining Toll signaling in Drosophila brain is required to sustain autophagy for dopamine neuron survival
    Jie Zhang, Ting Fang Tang, Ruonan Zhang, Liang Wen, Xiaojuan Deng, Xiaoxia Xu, Wanying Yang, Fengliang Jin, Yang Cao, Yuzhen Lu et al. · 2024 · iScience
53. Hypermethylation of Mest promoter causes aberrant Wnt signaling in patients with Alzheimer’s disease
    Renuka Prasad, Hwajin Jung, Anderson Tan, Yonghee Song, Sungho Moon, Mohammed R. Shaker, Woong Sun, Jung-Hee Lee, Hoon Ryu, Hyun Kook Lim et al. · 2021 · Scientific Reports
54. Simulating the multicausality of Alzheimer's disease with system dynamics
    Jeroen F. Uleman, René J. F. Melis, Eva Ntanasi, Nikolaos Scarmeas, Alfons G. Hoekstra, Rick Quax, Marcel G. M. Olde Rikkert, the Alzheimer's Disease Neuroimaging Initiative · 2023 · Alzheimer s & Dementia
55. A proof of unlimited multistability for phosphorylation cycles
    Elisenda Feliu, Alan D Rendall, Carsten Wiuf · 2020 · Nonlinearity
56. Effect of Continuous Propofol Infusion in Rat on Tau Phosphorylation with or without Temperature Control
    Chunxia Huang, Olivia Tsz-Wa Ng, Janice Yuen Shan Ho, Michael G. Irwin, Raymond Chuen‐Chung Chang, Gordon Tin Chun Wong · 2016 · Journal of Alzheimer s Disease
57. P301 L, an FTDP-17 Mutant, Exhibits Enhanced Glycation in vitro
    Shweta Kishor Sonawane, Subashchandrabose Chinnathambi · 2020 · Journal of Alzheimer s Disease
58. Loss of DEK Expression Induces Alzheimer’s Disease Phenotypes in Differentiated SH-SY5Y Cells
    Allie N. Greene, Lois G. Parks, Matia B. Solomon, Lisa M. Privette Vinnedge · 2020 · Frontiers in Molecular Neuroscience
59. Dose-dependent phosphorylation of endogenous Tau by intermittent hypoxia in rat brain
    Alexandria B. Marciante, John Clair Howard, Mia N. Kelly, Juan Santiago‐Moreno, Latoya Lynn Allen, Elisa Janine Gonzalez‐Rothi, Gordon S. Mitchell · 2022 · Journal of Applied Physiology
60. The Involvement of Post-Translational Modifications in Regulating the Development and Progression of Alzheimer’s Disease
    Pei-Pei Guan, Pu Wang · 2023 · Molecular Neurobiology
61. Novel aspects of the phosphorylation and structure of pathological tau: implications for tauopathy biomarkers
    Taeko Kimura, Haruaki Sato, Maria Kano, Lisa Tatsumi, Taisuke Tomita · 2023 · FEBS Open Bio
62. Recent advances in the development of immunotherapies for tauopathies
    Kiren K. Ubhi, Eliezer Masliah · 2010 · Experimental Neurology
63. Spreading of Pathology in Alzheimer’s Disease
    Zhongyue Lv, Chen‐Chen Tan, Jin‐Tai Yu, Lan Tan · 2017 · Neurotoxicity Research
64. Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer’s disease
    Karl Hansson, Rahil Dahlén, Oskar Hansson, Elin Pernevik, Ross W. Paterson, Jonathan M. Schott, Nadia K. Magdalinou, Henrik Zetterberg, Kaj Blennow, Johan Gobom · 2019 · Clinical mass spectrometry
65. Untangling the Conformational Polymorphism of Disordered Proteins Associated With Neurodegeneration at the Single-Molecule Level
    Melissa Birol, Ana M. Melo · 2020 · Frontiers in Molecular Neuroscience
66. Increased Phosphorylation of Tau and Synaptic Protein Loss in the Aged Transgenic Mice Expressing Familiar Alzheimer’s Disease-Linked Presenilin 1 Mutation
    Xifei Yang, Ying Yang, Jianjun Liu, Geng Li, Edward S. Yang · 2011 · Neurochemical Research
67. Nav1.7 sodium channel-induced Ca2+ influx decreases tau phosphorylation via glycogen synthase kinase-3β in adrenal chromaffin cells
    Tasuku Kanai, Takayuki Nemoto, Toshihiko Yanagita, Toyoaki Maruta, Shinya Satoh, Norie Yoshikawa, Akihiko Wada · 2009 · Neurochemistry International
68. Microtubule stabilising peptides rescue tau phenotypes in-vivo
    Shmma Quraishe, Megan A. Sealey, Louise Cranfield, Amritpal K. Mudher · 2016 · Scientific Reports
69. Arsenic and Tau Phosphorylation: A Mechanistic Review
    Ariafar, Saba, Makhdoomi, Sajjad, Mohammadi, Mojdeh · 2023 · Biological Trace Element Research
70. HMGCS2-Induced Autophagic Degradation of Tau Involves Ketone Body and ANKRD24
    Hu, Li-Tian, Xie, Xiao-Yong, Zhou, Gui-Feng, Wen, Qi-Xin, Song, Li, Luo, Biao, Deng, Xiao-Juan, Pan, Qiu-Ling, Chen, Guo-Jun · 2023 · Journal of Alzheimer's Disease
71. Neuropeptide Kyotorphin (Tyrosyl-Arginine) has Decreased Levels in the Cerebro-Spinal Fluid of Alzheimer’s Disease Patients: Potential Diagnostic and Pharmacological Implications
    Sara Santos, Laura García‐Nimo, Sónia Sá Santos, Isaura Tavares, Jose Angel Cocho, Miguel A. R. B. Castanho · 2013 · Frontiers in Aging Neuroscience
72. The Use of Polyphenols for the Treatment of Alzheimer’s Disease
    Sethuraman Sathya, Kasi Pandima Devi · 2018 · Elsevier eBooks
73. Dissecting Alzheimer's Disease Molecular Substrates by Proteomics and Discovery of Novel Post-translational Modifications
    Sayali Chandrashekhar Deolankar, Arun H. Patil, Shashanka G. Koyangana, Yashwanth Subbannayya, Thottethodi Subrahmanya Keshava Prasad, Prashant Kumar Modi · 2019 · OMICS A Journal of Integrative Biology
74. Activation of Neuronal Defense Mechanisms in Response to Pathogenic Factors Triggering Induction of Amyloidosis in Alzheimer's Disease
    Alexander V. Maltsev, Rasa Santockyte, Simon M. Bystryak, Oxana V. Galzitskaya · 2014 · Journal of Alzheimer s Disease
75. Microtubule proteins and their post-translational forms in the cerebrospinal fluid of patients with paraparesis associated with HTLV-I infection and in SH-SY5Y cells: an in vitro model of HTLV-I-induced disease.
    Horacio Maldonado, Emilio Ortiz-Riaño, B. Krause, A. Barriga, Fernando Medina, M. E. Pando, C. Alberti, A. Kettlun, L. Collados, L. Garcı́a et al. · 2008 · Biological Research
76. Dihydrotanshinone I Increase Amyloid-β Clearance and Decrease Tau Phosphorylation via Enhancing Autophagy
    Zhonglei Bao, Huixue Zhang, Hong Jiao, Xiaojie Chu, Jin Xiang Fu, Lihua Wang · 2020 · Pharmacology
77. cPKCγ Deficiency Exacerbates Autophagy Impairment and Hyperphosphorylated Tau Buildup through the AMPK/mTOR Pathway in Mice with Type 1 Diabetes Mellitus
    Jiayin Zheng, Yue Wang, Yue Liu, Song Han, Ying Zhang, Yanlin Luo, Yi Yan, Junfa Li, Li Zhao · 2022 · Neuroscience Bulletin
78. Enzyme-Responsive Supramolecular Self-Assembly in Small Amphiphiles
    Xiao Xiao, Jianbin Huang · 2024 · Langmuir
79. The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases
    Michael Klonarakis, Maya De Vos, Emma K. Woo, Liam T. Ralph, Jonathan S. Thacker, Joana Gil‐Mohapel · 2022 · Neuroscience & Biobehavioral Reviews
80. Alterations in Cerebellar Microtubule Cytoskeletal Network in a ValproicAcid-Induced Rat Model of Autism Spectrum Disorders
    Magdalena Gąssowska-Dobrowolska, Agnieszka Kolasa, David Quentin Beversdorf, Agata Adamczyk · 2022 · Biomedicines
81. Yuanzhi Powder inhibits tau pathology in SAMP8 mice: Mechanism research of a traditional Chinese formula against Alzheimer's disease
    Bin Li, Jiaxin Li, Yanwei Hao, Peijun Xie, Shengnan Yue, Shaofeng Wang, Jing Zhang, Yi Zhang · 2023 · Journal of Ethnopharmacology
82. Prolonged nitric oxide treatment induces tau aggregation in SH-SY5Y cells
    Muneaki Takahashi, Yo Chin, Takashi Nonaka, Masato Hasegawa, Nobuo Watanabe, Takao Arai · 2012 · Neuroscience Letters
83. Effect of tibolone pretreatment on kinases and phosphatases that regulate the expression and phosphorylation of Tau in the hippocampus of rats exposed to ozone
    Christian Guerra‐Araiza, Rodolfo Pinto‐Almazán, Julia J. Segura-Uribe, Marvin Antonio Soriano-Ursua, Eunice D. Farfán‐García, Juan Manuel Gallardo · 2018 · Neural Regeneration Research
84. Tau Protein and Zebrafish Models for Tau-Induced Neurodegeneration
    Yuanting Ding, Lijuan Lei, Chencen Lai, Zhi Tang · 2019 · Journal of Alzheimer s Disease
85. AMPK activators for the prevention and treatment of neurodegenerative diseases
    Natalie R. Neumann, David C. Thompson, Vasilis Vasiliou · 2021 · Expert Opinion on Drug Metabolism & Toxicology
86. Inhibition of TGF-β Signaling Attenuates Disuse-induced Trabecular Bone Loss After Spinal Cord Injury in Male Mice
    Karim Sahbani, Christopher P. Cardozo, William A. Bauman, Hesham A. W. Tawfeek · 2021 · Endocrinology
87. Trans-Channel Fluorescence Learning Improves High-Content Screening for Alzheimer's Disease Therapeutics
    Daniel R. Wong, Jay C. Conrad, Noah R. Johnson, Jacob I. Ayers, Annelies Laeremans, Joanne C. Lee, Jisoo Lee, Stanley B. Prusiner, Sourav Bandyopadhyay, Atul Janardhan Butte et al. · 2021 · Nature Machine Intelligence
88. Targeting mRNA for Alzheimer’s and Related Dementias
    Michael S. Wolfe · 2014 · Scientifica
89. Recent advances in pre-clinical diagnosis of Alzheimer’s disease
    John Zhou, Marc Benoit, Md Golam Sharoar · 2021 · Metabolic Brain Disease
90. Oxygen Enrichment Mitigates High-Altitude Hypoxia-Induced Hippocampal Neurodegeneration and Memory Dysfunction Associated with Attenuated Tau Phosphorylation
    Jing Cai, Junyong Ruan, Xi Shao, Yuanjun Ding, Kangning Xie, Chi Tang, Zedong Yan, Erping Luo, Da Jing · 2021 · High Altitude Medicine & Biology
91. (-)-SCR1693 Protects against Memory Impairment and Hippocampal Damage in a Chronic Cerebral Hypoperfusion Rat Model
    Xiaoyin Zhu, Jingwei Tian, Songmei Sun, Qiuju Dong, Fangxi Zhang, Xiumei Zhang · 2016 · Scientific Reports
92. Our Tau Tales from Normal to Pathological Behavior
    Alejandra del C. Alonso, Leah S. Cohen · 2018 · Journal of Alzheimer s Disease
93. Non-Proteasomal UbL-UbA Family of Proteins in Neurodegeneration
    Salinee Jantrapirom, Luca Lo Piccolo, Masamitsu Yamaguchi · 2019 · International Journal of Molecular Sciences
94. Association of cerebrospinal fluid zinc-α2-glycoprotein and tau protein with temporal lobe epilepsy and related white matter impairment
    Lijuan Mo, Xueying Ding, Changhong Tan, Xi Liu, Xin Paul Wei, Hui Wang, Wen Zhou, Lifen Chen · 2019 · Neuroreport
95. STOX1A induces phosphorylation of tau proteins at epitopes hyperphosphorylated in Alzheimer's disease
    Daan van Abel, Omar Abdul-Hamid, Wiep Scheper, Marie van Dijk, Cees B.M. Oudejans · 2012 · Neuroscience Letters
96. Expression pattern of Tau in the rat brain during pregnancy and the beginning of lactation
    Aliesha González‐Arenas, Ana Gabriela Piña-Medina, Oscar González‐Flores, Porfirio Gómora‐Arrati, Graciela Elena Carrillo-Martínez, Marco Antonio Balandrán-Ruíz, Ignacio Camacho‐Arroyo · 2012 · Brain Research Bulletin
97. Aging-induced alterations in microglial cells and their impact on neurodegenerative disorders
    Hridaya Singh, Rahul Gupta, Madhu Gupta, Ausaf Ahmad · 2025 · Molecular Biology Reports
98. Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: an update of the literature
    Tina Milos, Barbara Vuić, Nikola Balic, Vladimir Farkaš, Gordana Nedić Erjavec, Dubravka Švob Štrac, Matea Nikolac Perković, Nela Pivac · 2024 · Expert Review of Neurotherapeutics
99. Detection and identification of O -GlcNAc-modified proteins using 6-azido-6-deoxy- N -acetyl-galactosamine
    Jianshuang Guo, Guoqiang Zhang, Jing Ma, Caili Zhao, Qingqing Xue, Jiyan Wang, Wenjie Liu, Kaihui Liu, Haifeng Wang, Ning Liu et al. · 2019 · Organic & Biomolecular Chemistry
100. Role of Basal Forebrain Neurons in Adrenomyeloneuropathy in Mice and Humans
     Gong, Yi, Laheji, Fiza, Berenson, Anna, Li, Yedda, Moser, Ann, Qian, April, Frosch, Matthew, Sadjadi, Reza, Hahn, Ryan, Maguire, Casey A. et al. · 2024 · Annals of Neurology